» Articles » PMID: 24907474

Immunomodulatory Properties of Cell Wall Extract from Enterococcus Faecalis CECT7121

Overview
Date 2014 Jun 8
PMID 24907474
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the immunomodulatory properties of cell wall extract from Enterococcus faecalis CECT7121, measuring the induction of cytokines TNF-α, IL-6, IL-10 and IL-12 from human peripheral blood mononuclear cells (PBMCs). Cell wall extract was prepared from their growth in brain heart infusion broth (18h, 35°C). Subsequently, toxicity of the obtained cell wall extract was tested in Balb-C mice. PBMCs were isolated from buffy coats at the Blood Transfusion Service of Hospital Ramón Santamarina (Tandil, Argentina). PBMCs were purified using standard Ficoll-Paque gradient centrifugation. Aliquots of purified leukocytes were incubated at 37°C for 24h with heat-killed E. faecalis CECT7121 and cell wall extract. Concentrations of IL-6, TNFα, IL-10 and IL-12 (p70) were measured by solid phase sandwich ELISA. Changes in appearance and behavior of mice were evidenced only in the group with the maximal concentration of wall cell extract used (10,000μg). Cell wall extract and heat-killed E. faecalis CECT7121 induced the production of significantly higher amounts of Il-12, IL-6, TNF-α and IL-10 cytokines compared to the nonstimulated PBMCs. These findings provide helpful information on immunomodulation activity by cell wall extract in sight of the application of this compound in controlling certain infectious diseases.

Citing Articles

Concomitant Therapy of Inactivated CECT7121 with Fluoroquinolones in a Enteritidis Murine Sepsis Model.

Schofs L, Sparo M, Garcia Allende N, de Yaniz M, Confalonieri A, Sanchez Bruni S Indian J Microbiol. 2024; 64(4):1956-1960.

PMID: 39678964 PMC: 11645324. DOI: 10.1007/s12088-024-01192-y.


Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method.

Petakh P, Kobyliak N, Kamyshnyi A Front Cell Infect Microbiol. 2023; 13:1142578.

PMID: 36844398 PMC: 9947359. DOI: 10.3389/fcimb.2023.1142578.


Bacteria associated with apical periodontitis promotes in vitro the differentiation of macrophages to osteoclasts.

Torres-Monjaras A, Sanchez-Gutierrez R, Hernandez-Castro B, Gonzalez-Baranda L, Alvarado-Hernandez D, Pozos-Guillen A Clin Oral Investig. 2023; 27(6):3139-3148.

PMID: 36800026 DOI: 10.1007/s00784-023-04920-8.


Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm.

Zeinali T, Faraji N, Joukar F, Khan Mirzaei M, Kafshdar Jalali H, Shenagari M Microb Pathog. 2022; 170:105704.

PMID: 35948266 PMC: 9357283. DOI: 10.1016/j.micpath.2022.105704.


Enterococci from Raw-Milk Cheeses: Current Knowledge on Safety, Technological, and Probiotic Concerns.

Terzic-Vidojevic A, Veljovic K, Popovic N, Tolinacki M, Golic N Foods. 2021; 10(11).

PMID: 34829034 PMC: 8624194. DOI: 10.3390/foods10112753.


References
1.
Gill H, Shu Q, Lin H, Rutherfurd K, Cross M . Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med Microbiol Immunol. 2002; 190(3):97-104. DOI: 10.1007/s004300100095. View

2.
Besselink M, van Santvoort H, Buskens E, Boermeester M, Goor H, Timmerman H . Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 371(9613):651-659. DOI: 10.1016/S0140-6736(08)60207-X. View

3.
Opal S . New perspectives on immunomodulatory therapy for bacteraemia and sepsis. Int J Antimicrob Agents. 2010; 36 Suppl 2:S70-3. DOI: 10.1016/j.ijantimicag.2010.11.008. View

4.
Sparo M, Nunez G, Castro M, Calcagno M, Garcia Allende M, Ceci M . Characteristics of an environmental strain, Enterococcus faecalis CECT7121, and its effects as additive on craft dry-fermented sausages. Food Microbiol. 2008; 25(4):607-15. DOI: 10.1016/j.fm.2008.01.008. View

5.
Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K . Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol. 2004; 70(2):1176-81. PMC: 348788. DOI: 10.1128/AEM.70.2.1176-1181.2004. View